Overcoming Barriers to Treatment of Opioid Use Disorder

An interview with Dr Bauchner is presented. Highlight of the discussion is the federal guidance that would exempt physicians from a standing requirement to apply for a waiver to prescribe buprenorphine for opioid use disorder (OUD) and makes additional recommendations to expand access to medication...

Full description

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 2021-03, Vol.325 (12), p.1149-1150
Main Authors: Olsen, Yngvild, Fitzgerald, Ruchi M, Wakeman, Sarah E
Format: Article
Language:English
Subjects:
Analgesics, Opioid - therapeutic use
Buprenorphine
Buprenorphine - therapeutic use
Drug addiction
Education, Medical - legislation & jurisprudence
Health Policy
Humans
Legislation, Drug
Methadone
Narcotics
Opiate Substitution Treatment
Opioid-Related Disorders - drug therapy
Opioids
Physicians
Practice Guidelines as Topic
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An interview with Dr Bauchner is presented. Highlight of the discussion is the federal guidance that would exempt physicians from a standing requirement to apply for a waiver to prescribe buprenorphine for opioid use disorder (OUD) and makes additional recommendations to expand access to medication treatment of OUD, including expanded prescriber training and office-based methadone treatment.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2021.1741